Literature DB >> 12139595

Delivery characteristics of a combined nitric oxide nasal continuous positive airway pressure system.

R Lindwall1, C G Frostell, P A Lönnqvist.   

Abstract

BACKGROUND: Nitric oxide (NO), when inhaled, has a synergistic effect with airway recruitment strategies such as positive endexpiratory pressure (PEEP) or continuous positive airway pressure (CPAP) in improving oxygenation in lung injury.
METHODS: We modified a commercially available nasal CPAP (nCPAP) system to enable the concomitant delivery of inhaled NO (iNO) and nCPAP to neonates and term babies. Oxygen, NO and nitrogen dioxide (NO2) concentrations were measured, comparing the effects of using 50 or 1000 parts per million (p.p.m.) NO stock gas cylinders.
RESULTS: Stable and accurate delivery of iNO was found for both stock gas concentrations. Using a 50 p.p.m. NO stock gas resulted in limited NO2 formation, with a maximum inspired NO2 concentration of < or = 0.3 p.p.m. (dose range up to 37 p.p.m. iNO), which was interpreted as the result of progressive dilution with nitrogen. In contrast, using a 1000 p.p.m. NO stock gas cylinder, inspired NO2 levels increased nonlinearly as expected with an increasing inspired concentration of NO.
CONCLUSIONS: Inhaled NO can be safely and reliably delivered by the system we describe. The NO2 levels generated by the system are low, at least up to a dose of 37 p.p.m. NO, regardless of a stock gas concentration of 50 or 1000 p.p.m. NO. Using a 50 p.p.m. NO stock gas concentration, up to 80% oxygen can be given at 10 p.p.m. iNO.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139595     DOI: 10.1046/j.1460-9592.2002.00898.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  4 in total

1.  Workplace NO and NO2 during combined treatment of infants with nasal CPAP and NO.

Authors:  Robert Lindwall; Mats E Svensson; Claes G Frostell; Staffan Eksborg; Lars E Gustafsson
Journal:  Intensive Care Med       Date:  2006-10-17       Impact factor: 17.440

2.  A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome.

Authors:  Robert Lindwall; Mats Blennow; Mats Svensson; Baldvin Jonsson; Eva Berggren-Boström; Martino Flanby; Per-Arne Lönnqvist; Claes Frostell; Mikael Norman
Journal:  Intensive Care Med       Date:  2005-03-22       Impact factor: 17.440

Review 3.  Inhaled nitric oxide therapy in neonates and children: reaching a European consensus.

Authors:  Duncan J Macrae; David Field; Jean-Christophe Mercier; Jens Møller; Tom Stiris; Paolo Biban; Paul Cornick; Allan Goldman; Sylvia Göthberg; Lars E Gustafsson; Jürg Hammer; Per-Arne Lönnqvist; Manuel Sanchez-Luna; Gunnar Sedin; Nim Subhedar
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

4.  Non-invasive inhaled nitric oxide in the treatment of hypoxemic respiratory failure in term and preterm infants.

Authors:  R Sahni; X Ameer; K Ohira-Kist; J-T Wung
Journal:  J Perinatol       Date:  2016-10-06       Impact factor: 2.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.